All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...703Next →

hiv & aids news selected from other sources

  • The search for a cure
    The Big Picture of Small Molecules for Curing HIV Infection
    AVAC | 3 hours ago

    Dr. David Margolis and Karine Dubé of The Martin Delaney Collaboratory of AIDS Researchers for Eradication explain one strategy being pursued by scientists as a possible way to cure HIV. After reading this, if you want to learn more check out this video on related research.

  • Promoting HIV testing
    HIV Trends in San Francisco and London: An AIDS 2014 Q&A
    BETA blog | 3 hours ago

    At AIDS 2014 researchers presented findings from a comparison of HIV trends in two major cities: San Francisco and LondonStudy co-author Jen Hecht, MPH, director of program development and operations at San Francisco AIDS Foundation, spoke with BETA about the study findings, what they mean for HIV prevention efforts moving forward

  • The search for a cure
    Vault nanoparticles engineered at UCLA show promise for cancer treatment and possible HIV cure
    UCLA press release | 3 hours ago

    UCLA scientists developed a method for placing bryostatin 1 in nanoscale vaults for safe delivery to cells, where it can activate latent HIV, enabling the virus to be eradicated.

  • The search for a cure
    iCo Therapeutics Announces Positive Oral Amphotericin B Study Results
    iCo Therapeutics press release | 3 hours ago

    iCo Therapeutics Inc. ("iCo" or "the Company") today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs.

  • Promoting HIV testing
    Gay Social Networking App Hornet Helps Users Find HIV Clinics
    Towleroad | 3 hours ago

    Hornet will provide users with the ability to designate their HIV status, as a part of its “Know Your Status” campaign. Once a user designates the date of their last HIV test, the application will automatically remind them to get tested again after a designated amount of time.

  • Vaccines
    Mechanism found for development of protective HIV antibodies
    Science Daily | 3 hours ago

    Scientists have found an immunologic mechanism that makes broadly neutralizing antibodies in people who are HIV-1 infected. The research team found that two distinct B-cell lineage antibodies teamed up to stimulate the highly sought-after broadly neutralizing antibodies to HIV. The induction of these antibodies that can neutralize a variety of HIV strains is a key strategy for a global vaccine, they say.

  • PrEP
    So Why Are So Many Gay Men Opposed To PrEP?
    TheGayUK | 19 hours ago

    "About nine months ago, the GUM clinic I regularly attend (the Working Men’s Project at St Mary’s in Paddington) offered me the chance to be part of the PROUD study, which examines the impact on gay men of using Pre-Exposure Prophylaxis (PrEP), and I jumped at the chance, not only because I wanted to do my bit for the community, but because it offered me an extra level of protection against HIV, regardless of whether I was using condoms or not."

  • Hepatitis C treatment
    The Risky Business of Limiting Medicaid Access to Sovaldi
    Governing | 21 August 2014

    Partially because of its high cost, nearly half the states are restricting Medicaid patients' access to an effective new hepatitis C drug. Experts say there’s no question lawsuits will come.

  • New report finds missing and incomplete data imperils the global HIV/AIDS response
    AVAC | 21 August 2014

    A new report from amfAR, The Foundation for AIDS Research, and AVAC outlines the need for a new approach to tracking data to guide the key decisions that shape the response to the HIV/AIDS epidemic. Critical and expensive decisions made with incomplete data are undermining the response—even as the systems for collecting this data continue to improve, the report found.

  • Hepatitis C treatment
    Nearly Half of Surveyed US Specialists Expect to Prescribe Gilead's Sofosbuvir / Ledipasvir Regimen Near-Term for Hepatitis C Infections
    Decision Resources Group press release | 21 August 2014

    Analysis of surveyed specialists' near-term prescribing intent indicates that nearly one in every four actively treated genotype 1 patients will be prescribed the sofosbuvir/ledipasvir regimen in the next six months. However, the on-treatment patient shares for the off-label Olysio (Janssen) and Sovaldi combination regimen are expected to remain stable over this period.

← First12345...929Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.